Posted on: 25th April 2018
We have published our resource portal for Continued Process Verification (CPV&I) following the publication of the Legacy Products guidance document at the end of 2017. You will now be able to access all guidance documents, articles and further support through this one section on our website, making it easier for you to access and share the information.
The resources made available allow for manufacturers in the biopharmaceutical sector to appropriately respond to guidance made by the FDA in 2011. The tools were created as a consensus view of an acceptable CPV program; they are not an exact representation of the internal policies of any contributing company. They are intended as a basis upon which companies in the biopharmaceutical industry can build and share developing knowledge.